Asymptomatic arrhythmias are frequently encountered in clinical practice. Although studies
specifically dedicated to these asymptomatic arrhythmias are lacking, many arrhythmias still …

With the continuous improvement in survival of cancer patients, including those with multiple
myeloma, related to the novel treatment agents and therapeutic approaches, the probability …

АВ—атриовентрикулярный (ая) АГ—артериальная гипертензия АД—артериальное
давление АТ—артериальный тромбоз АТО—атеротромботические осложнения АТФ …

Abstract Purpose of Review Due to advancements in oncologic treatment strategies and
techniques, the number of survivors who have undergone hematopoetic stem cell transplant …

The use of hematopoietic cell transplantation (HCT) has expanded in the last 4 decades to
include an older and more comorbid population. These patients face an increased risk of …

The ongoing coronavirus disease 2019 (COVID-19) pandemic has resulted in efforts to
identify therapies to ameliorate adverse clinical outcomes. The recognition of the key role for …

Background Although most studies on the cardiovascular toxicity of proteasome inhibitors
have focused on carfilzomib, the risk of cardiotoxicity associated with bortezomib remains …

Many drugs used in hematopoietic stem cell transplantation (HSCT) settings have the
potential to cause adverse cardiovascular effects. Drug-induced cardiotoxicity is a serious …

Purpose High-dose chemotherapy followed by autologous stem cell transplantation (ASCT)
is the standard management for relapsed or high-risk non-Hodgkin's lymphoma (NHL). We …

Chemotherapy-induced cardiotoxicity is a known condition, however, bortezomib and
melphalan do not typically cause cardiotoxicity. With the rise in the use of newer …